| Literature DB >> 35052998 |
Lidwine Ngah1, Willifred Dongmo Tékapi Tsopgni1, Judith Caroline Ngo Nyobe2, Alain Tadjong Tcho3, Moses K Langat4, Jean Claude Ndom1, Eduard Mas-Claret4, Nicholas John Sadgrove4, Alain François Kamdem Waffo1, Methee Phumthum4,5.
Abstract
A chemical investigation of the leaves of Tabernaemontana inconspicua Stapf. led to the isolation of a new phenylpropanol derivative, namely irisdichototin G (1), together with nine known compounds, including one polyol derivative, dambonitol (2); three alkaloids, 10-hydroxycoronaridine (3), voacristine (4) and vobasine (5); two triterpenes lupeol (6), betulinic acid (7) and three sterols, sitosterol (8), sitosterol-3-O-β-D-glucopyranoside (9) and stigmasterol (10). The structure of the new compound, as well as those of the known ones, was established by means of spectroscopic methods: NMR analysis (1H and 13C NMR, 1H-1H-COSY, HSQC, HMBC and NOESY), high-resolution mass spectrometry (HR-ESI-MS) and comparisons with previously reported data. Among the known compounds, compound 2 was firstly reported from the family Apocynaceae. Compounds 1-5 were tested for their antimicrobial effects against three Gram-negative organisms associated with human wound and systemic infections, namely Haemophilus influenzae 9435337A, Klebsiella pneumoniae 17102005 and Pseudomonas aeruginosa 2137659B. Compounds 1, 3, and 5 showed significant antimicrobial effects with minimum inhibitory concentrations (MIC) of 62.5 μg/mL, 62.5 μg/mL and 7.81 μg/mL, respectively, against Haemophilus influenzae, whereas compounds 1 and 5 showed significant antimicrobial effects, with a MIC value of 31.25 μg/mL against Pseudomonas aeruginosa. In addition, compound 3 showed significant antimicrobial activity, with a MIC value of 31.25 μg/mL against Klebsiella pneumoniae.Entities:
Keywords: Apocynaceae; Tabernaemontana inconspicua; alkaloids; antimicrobial; irisdichototin G
Year: 2022 PMID: 35052998 PMCID: PMC8773313 DOI: 10.3390/antibiotics11010121
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
1H (500 MHz) and 13C NMR (125 MHz) data for compound (1) in MeOD.
| Position | δC | δH (Mult.; J) |
|---|---|---|
| 1 | 74.1 | 4.54 (1H, d, J = 6.2) |
| 2 | 76.2 | 3.69 (1H, m) |
| 3 | 62.9 | 3.69 (1H, m)3.50 (1H, m) |
| 1′ | 104.0 | / |
| 2′ | 110.2 | 7.02 (1H, d, J = 2.0) |
| 3′ | 133.5 | / |
| 4′ | 147.4 | / |
| 5′ | 114.3 | 6.71 (1H, dd, J = 8.0 ; 2.0) |
| 6′ | 119.2 | 6.80 (1H, d, J = 8.0) |
| CH3O- | 55.0 | 3.88 (1H, m) |
Figure 1Key 1H-1H COSY and HMBC correlations of compound 1.
Figure 2Key NOESY correlation of compound 1.
Figure 3Chemical structures of compounds 1–10 from T. inconspicua.
Average inhibitory and bactericidal concentrations (MIC and MBC) of the crude extract and compounds 1–5.
| Samples | Inhibitory Parameters (µg/mL) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| MIC | MBC | MBC/MIC | MIC | MBC | MBC/MIC | MIC | MBC | MBC/MIC | |
| Crude Extract | 15.625 | 62.5 | 4 | 31.25 | 125 | 4 | 62.5 | 125 | 2 |
| 1 | 62.5 | 125 | 2 | 125 | 250 | 2 | 31.25 | >250 | ND |
| 2 | >250 | >250 | ND | >250 | >250 | ND | >250 | >250 | ND |
| 3 | 62.5 | 125 | 2 | 125 | 250 | 2 | 250 | >250 | ND |
| 4 | >250 | >250 | ND | >250 | >250 | ND | >250 | >250 | ND |
| 5 | 7.81 | 31.25 | 4 | 31.25 | 125 | 4 | 31.25 | 125 | 4 |
| Levofloxacin | 1.95 | 7.81 | 4 | 0.48 | 1.95 | 4 | 0.48 | 1.95 | 4 |
ND: not determined; MIC = Minimum inhibitory concentration; MBC = Minimum bactericidal concentration; The ratio MBC/MIC determine the bactericidal (MBC/MIC ≤ 4) or bacteriostatic (MBC/MIC > 4) effects of extracts. The activity of plant extract and compounds will be classified as significant (MIC < 100 µg/mL), moderate (100–625 µg/mL), or weak (MIC > 250 µg/mL).